Whitehawk Therapeutics, Inc. (WHWK) Stock Analysis

Whitehawk Therapeutics, Inc. (WHWK) is a publicly traded company in the HEALTHCARE sector. It trades at $4.18, carries a market capitalization of $222.04M. This page summarizes the public market data, fundamentals, and frequently asked questions for WHWK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Whitehawk Therapeutics, Inc. currently has a Bullish sentiment score of 0.22.

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc. is a pioneering oncology therapeutics company headquartered in Morristown, New Jersey, dedicated to transforming cancer treatment through its proprietary technologies that enhance tumor biology understanding. The firm is focused on developing targeted therapies that optimize patient outcomes by personalizing treatment strategies based on the specific biological profiles of individual tumors. With its strong commitment to precision medicine, Whitehawk is poised to ...

GNG Research Analysis

GNG Research scores Whitehawk Therapeutics, Inc. (WHWK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for WHWK.

Frequently Asked Questions

Does WHWK pay dividends?

Whitehawk Therapeutics, Inc. (WHWK) does not currently pay a regular dividend.

What is WHWK's market cap?

Whitehawk Therapeutics, Inc. (WHWK) has a market capitalization of $222.04M with a current stock price of $4.18.